OXFORD UNIVERSITY PRESS

50 Studies Every Ophthalmologist Should Know

ISBN : 9780190050726

Price(incl.tax): 
¥10,769
Author: 
Alan Penman; Kimberley Crowder; Michael E. Hochman; William M. Watkins
Pages
352 Pages
Format
Paperback
Size
156 x 235 mm
Pub date
Feb 2020
Send mail
Print

50 Studies Every Ophthalmologist Should Know presents key studies that have shaped the practice of ophthalmology. Selected using a rigorous methodology, emphasis has been placed on landmark studies which have influenced current ophthalmology practice guidelines. For each study, a concise summary is presented with an emphasis on the results and limitations of the study, and its implications for practice. An illustrative clinical case concludes each review, followed by brief information on other relevant studies. This book is a must-read for ophthalmologists, especially those in training or preparing for board review, as well as anyone who wants to learn more about the data behind clinical practice.

Index: 

1. Effectiveness of Histocompatibility Matching in High-Risk Corneal Transplantation
2. Topical Corticosteroids for Herpes Simplex Stromal Keratitis
3. Topical Corticosteroids for Bacterial Keratitis
4. Topical Natamycin versus Voriconazole for Fungal Corneal Ulcer
5. Prevalence of Age-Related Lens Opacities in a Population
6. Risk Factors for Cataract
7. High-Dose Supplementation with Vitamins C and E and Beta Carotene for Age-Related Cataract and Vision Loss
8. Routine Preoperative Medical Testing Before Cataract Surgery.
9. Prophylaxis of Postoperative Endophthalmitis Following Cataract Surgery
10. The Relationship Between Optic Disc Area and Open-Angle Glaucoma
11. Is argon laser trabeculoplasty equivalent to topical medication as an initial treatment for primary open-angle glaucoma?
12. Intraocular Pressure Reduction in the Treatment of Normal-Tension Glaucoma
13. The Relationship Between Control of Intraocular Pressure after Surgical Intervention for Glaucoma and Visual Field Deterioration
14. Reduction of intraocular pressure and glaucoma progression
15. Topical ocular hypotensive medication to delay or prevent the onset of primary open-angle glaucoma
16. Intraocular Pressure Control and Long-Term Visual Field Loss in Open-Angle Glaucoma
17. Latanoprost for Open-Angle Glaucoma
18. Tube Shunt Surgery Versus Trabeculectomy in Eyes with Prior Ocular Surgery and Uncontrolled Glaucoma
19. Pooled Data Analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study
20. Risk Factors for Branch and Central Retinal Vein Occlusion
21. Argon Laser Photocoagulation for Macular Edema in Branch Vein Occlusion
22. Intraocular Injections of Ranibizumab in Patients With Macular Edema Following Branch Retinal Vein Occlusion
23. Grid Pattern Photocoagulation for Macular Edema in Central Vein Occlusion
24. Steroids in the Treatment of Central Retinal Vein Occlusion
25. Cryotherapy for Retinopathy of Prematurity
26. Supplemental Therapeutic Oxygen for Pre-Threshold Retinopathy of Prematurity
27. Early Treatment of Prethreshold Retinopathy of Prematurity
28. Intravitreal Bevacizumab for Stage 3+ Retinopathy of Prematurity
29. Photocoagulation for Diabetic Macular Edema
30. Early Photocoagulation for Diabetic Retinopathy
31. Does Pars Plana Vitrectomy Improve Visual Outcomes in Patients with Complications of Proliferative Diabetic Retinopathy
32. Intensive Diabetes Management to Reduce the Risk of Retinopathy Developing or Progressing
33. Progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus
34. Immediate Vitrectomy and Intravenous Antibiotics for the Treatment of Postoperative Bacterial Endophthalmitis
35. Prevalence of Age-Related Maculopathy
36. Does high-dose supplementation with vitamins C and E, beta carotene, and zinc slow the progression of age-related macular degeneration and vision loss?
37. Argon laser photocoagulation for extrafoveal neovascular maculopathy
38. Photodynamic Therapy of Subfoveal Choroidal Neovascularization in Age-related Macular Degeneration with Verteporfin
39. Pegaptanib for Neovascular Age-Related Macular Degeneration
40. Ranibizumab for Neovascular Age-Related Macular Degeneration
41. Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration
42. Effect of Pre-Enucleation Radiation on Mortality in Large Choroidal Melanomas
43. Systemic Anti-Inflammatory Therapy versus Fluocinolone Acetonide
44. Botulinum A Toxin Injection into Extraocular Muscles as an Alternative to Strabismus Surgery
45. Botulinum A Toxin Injection as a Treatment for Blepharospasm
46. A Clinical Activity Score That Discriminates Between Inflammatory and Non-Inflammatory Graves' Ophthalmopathy
47. Corticosteroids in the Treatment of Acute Optic Neuritis
48. Atropine or Patching for Treatment of Moderate Amblyopia in Children
49. Contact Lens vs Intraocular Lens Correction of Monocular Aphakia During Infancy
50. Effect of Acetazolamide on Visual Function in Patients With Idiopathic Intracranial Hypertension and Mild Visual Loss

About the author: 

Dr. Alan Penman is a physician with specialty training in ophthalmology, public health, epidemiology, and biostatistics. He graduated MBChB from Aberdeen University Medical School, Scotland in 1979, and received an MSc in Clinical Tropical Medicine from London University, England in 1981, an MPH from the University of Alabama (Birmingham) in 1998, and a PhD in Biostatistics from the University of Mississippi in 2008. He completed his training in ophthalmology at Aberdeen Royal Infirmary in 1989, followed by a retinal fellowship at the MRC Sickle Cell Clinic in Kingston, Jamaica from 1990-1992. As a Professor in the Departments of Preventive Medicine and Ophthalmology at the University of Mississippi Medical Center (UMMC), Dr. Penman consults regularly with investigators conducting clinical studies and population research. In addition, he directs and teaches courses in epidemiology, biostatistics, public health and disease prevention for medical students and graduate medical faculty.; Dr. Kimberly Crowder is Professor and Chair of the Department of Ophthalmology at the University of Mississippi Medical Center. She completed her ophthalmology residency at UMMC in 2003, joining the department's faculty immediately afterward, and serving as the program director for the Medical Center's ophthalmology residents from 2007-2015. She was promoted to department chair in 2015. Dr. Crowder's motivation stems from her desire to improve ophthalmology education for residents and students. Since 2003, she has been an active attending physician in ophthalmology and filled multiple roles including course director for medical student electives in ophthalmology, course director of Family and Emergency Medicine resident rotations in ophthalmology, and director for the resident eye clinic. She has twice been named Ophthalmology Faculty of the year by the UMMC Ophthalmology residents. Dr. Crowder is board certified by the American Board of; Ophthalmology and practices comprehensive ophthalmology. She's a member of a number of professional societies, among them the American Academy of Ophthalmology, for which she is currently serving on a Residency education task force. She is also a member of the Association of American Medical Colleges' Council of Faculty and Academic Societies, as well as the Mississippi Academy of Eye Physicians and Surgeons, and the Association for Research in Vision and Ophthalmology.

The price listed on this page is the recommended retail price for Japan. When a discount is applied, the discounted price is indicated as “Discount price”. Prices are subject to change without notice.